May T, Wolf U, Wolffgramm J
Institut für Neuropsychopharmakologie, Freie Universität Berlin, Germany.
J Pharmacol Exp Ther. 1995 Dec;275(3):1195-203.
In this report a novel animal model of spontaneous development of alcohol and drug addiction was used. Addiction to ethanol was induced in male Wistar rats (free choice between ethanol solutions and water for 11 mo). After 36 wk of alcohol deprivation these rats (series A) had ingested 3.4 +/- 0.4 g ethanol/kg/day. Age-matched, "controlled" alcohol consumers (series C: free choice for 8 wk) had ingested only 1.6 +/- 0.4 g/kg/day (P < .001). Two additional series of addicted (AL) and controlled alcohol-consuming rats (CL) received lisuride (90 micrograms/kg/day) for 8 wk concomitantly with the self-administered ethanol and again during the last week before death. Ethanol intake was increased by lisuride treatment in both groups (AL: 4.1 +/- 0.3 g/kg/day; CL: 2.7 +/- 0.4 g/kg/day; P < .05). Four months before death the alcohol was withdrawn. After this period of abstinence the in vitro dose-response curves for striatal dopamine D-1 receptor-stimulated adenylyl cyclase activity were determined (with eight concentrations of dopamine between 50 nM and 30 microM). Both lisuride-treated (AL) and untreated ethanol-addicted rats (A) displayed a significant (P < .01) increase in the effective concentration required to induce 50% of the response (EC50) as compared with controlled drinkers (C: 720 +/- 150 nM; A: 1820 +/- 390 nM; CL: 590 +/- 110 nM; AL: 1050 +/- 160 nM). Lisuride treatment increased forskolin- (10 microM) stimulated adenylyl cyclase activity and the Bmax of high-affinity [3H]DA binding to the D-1 site.(ABSTRACT TRUNCATED AT 250 WORDS)
在本报告中,使用了一种新的酒精和药物成瘾自发发展的动物模型。在雄性Wistar大鼠中诱导乙醇成瘾(在乙醇溶液和水之间自由选择11个月)。在戒酒36周后,这些大鼠(A组)摄入乙醇的量为3.4±0.4克/千克/天。年龄匹配的“对照”饮酒大鼠(C组:自由选择8周)仅摄入1.6±0.4克/千克/天(P<.001)。另外两组成瘾(AL)和对照饮酒大鼠(CL)在自行摄入乙醇的同时接受了8周的利苏立得(90微克/千克/天)治疗,并在死亡前最后一周再次接受该治疗。利苏立得治疗使两组的乙醇摄入量均增加(AL组:4.1±0.3克/千克/天;CL组:2.7±0.4克/千克/天;P<.05)。在死亡前四个月停止供应酒精。在这段禁欲期后,测定纹状体多巴胺D-1受体刺激的腺苷酸环化酶活性的体外剂量反应曲线(使用50 nM至30 μM之间的八种多巴胺浓度)。与对照饮酒者相比,利苏立得治疗组(AL)和未治疗的乙醇成瘾大鼠(A)诱导50%反应所需的有效浓度(EC50)均显著增加(P<.01)(C组:720±150 nM;A组:1820±390 nM;CL组:590±110 nM;AL组:1050±160 nM)。利苏立得治疗增加了福斯高林(10 μM)刺激的腺苷酸环化酶活性以及高亲和力[3H]DA与D-1位点结合的Bmax。(摘要截断于250字)